FindTrial
Sign In

XL820

DRUG3 trials

Sponsors

Exelixis

Conditions

CancerGastrointestinal NeoplasmsGastrointestinal Stromal Tumors

Phase 1

Study of XL820 in Adults With Solid Tumors
CompletedNCT00129571
ExelixisCancer
Start: 2005-08-31Updated: 2008-06-04
Study of XL820 Given Orally Daily to Subjects With Solid Tumors
CompletedNCT00350831
ExelixisCancer
Start: 2006-07-31Target: 30Updated: 2008-08-18

Phase 2

A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
CompletedNCT00570635
ExelixisGastrointestinal Neoplasms, Gastrointestinal Stromal Tumors
Start: 2007-12-31End: 2009-05-31Updated: 2013-06-07